Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.01
Bid: 1.84
Ask: 1.96
Change: -0.14 (-6.86%)
Spread: 0.12 (6.522%)
Open: 2.00
High: 2.01
Low: 2.00
Prev. Close: 2.04
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

Wed, 30th Sep 2020 18:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Itaconix PLC - chemicals company - For 2019, pretax loss narrowed to USD1.4 million from USD10.1 million the year before, on revenue that grew by 46% to USD1.3 million from USD881,000, as a result of increased product demand, cost savings and new orders from customers in Europe.

----------

New Trend Lifestyle Group PLC - Singapore-based Feng Shui products maker - For first half of 2020, pretax loss widens to SGD1.4 million from SGD314,000 the year before, on revenue that fell by 38% to SGD1.9 million from SGD3.1 million, as retail outlets were closed due to lockdown restrictions.

----------

Immupharma PLC - pharmaceutical company - For the first half of 2020, pretax loss narrows to GBP3.1 million from GBP6.7 million the year before, on revenue that dropped to GBP62,207 from GBP77,925.

----------

Echo Energy PLC - Latin American-focused upstream oil and gas firm - For the first half of 2020, pretax loss narrows to USD5.7 million from USD7.9 million, on revenue that more than doubled to USD5.7 million from USD2.7 million, on production that came up to 390,844 barrels of oil equivalent.

----------

Goldstone Resources Ltd - Africa-focused gold resource developer - For the first half of 2020, pretax loss widens to USD292,098 from USD289,951 the year before, despite a fall in administrative expenses. During period, gained formal approval for ten-year mining lease on Akrokeri and Homase licences in Ghana.

----------

Quixant PLC - Cambridge-based technology outsourcer for gaming industry - For first half of 2020, swings to pretax loss of GBP3.0 million from profit of USD3.0 million the year before. On adjusted basis, pretax loss at USD1.4 million from profit of USD3.4 million, on revenue that declined to USD27.9 million from USD41.9 million. Looking ahead, expects return to profitable trading in second half of year.

----------

Aberdeen Standard European Logistics Income PLC - Investment trust - As at June 30, net asset value per share at EUR1.13 compared to EUR1.11 on December 31.

----------

Schroder UK Public Private Trust PLC - investment trust - As at June 30, net asset value per share fell 8.1% to 45.44 pence from 49.46p at the end of December 31.

----------

Trident Royalties PLC - London-based mining royalty firm - For the first half of 2020, pretax loss widens to USD1.1 million from USD138,844 the year before. Looking ahead, commodity markets have continued to strengthen in the third quarter, leading to a positive outlook for the rest of the year.

----------

Hemogenyx Pharmaceuticals PLC - pre-clinical stage biopharmaceutical firm headquartered in London - For the first half of 2020, pretax loss widens to GBP835,189 from GBP706,670 the year before due to rise in administrative costs. Keeps confident outlook due to significant progress on several development fronts, including CDX antibody research.

----------

Immotion Group PLC - immersive entertainment company headquartered in Manchester - For the first half of 2020, pretax loss remains flat at GBP2.6 million, on revenue that dropped to GBP818,000 from GBP1.3 million the year before, due to four months of trading being effectively lost to the Covid-19 lockdown.

----------

India Capital Growth Fund Ltd - investment fund - As at June 30, net asset value per share down 20% to 70.42 pence from 97.02p the same date the year before. Portfolio holds 32 investee companies, as seven holdings were sold and seven new investments were made.

----------

Chesterfield Resources PLC - copper-gold exploration and development company active in Cyprus - For the first half of 2020, pretax loss narrows to GBP257,465 from GBP303,704 the year before. Looking ahead, outlook for copper and gold is robust, as commodities rose following lockdowns.

----------

URU Metals Ltd - exploration and development - For the year to the end of March, pretax loss narrows to USD732,000 from USD2.3 million due to the absence of exceptional charges related to the impairment of group's 50% interest in the Burgersfort project and shares held in Management Resource Solutions PLC.

----------

Edenville Energy PLC - operator of the Rukwa coal project in southwest Tanzania - For 2019, pretax loss widens to GBP1.9 million from GBP1.8 million, as revenue declined to GBP233,414 from GBP337,125. The lack of capital following debt repayments in Tanzania affected the company's ability to increase production to targeted levels.

----------

ADM Energy PLC - natural resources investor with assets in Nigeria - For the first half of 2020, pretax loss widens to GBP975,000 from GBP448,000, due to no revenue being made for period, compared to GBP2.2 million the prior year. Total production from Aje field was 2,126 barrels of oil per day, down from 2,967 bopd.

----------

SEEEN PLC - London-based social media technology firm - For the first half of 2020, pretax loss widens to USD2.0 million from USD219,572 the year before on sharp rise in administrative expenses, despite generating revenue of USD3.7 million. For the third quarter, revenue improved as viewer growth accelerated.

----------

Predator Oil & Gas Holdings PLC - Jersey-based oil and gas company - For the first half of 2020, pretax loss widened to GBP784,156 from GBP512,263 the year before, as no revenue generated. Successfully executed phases one and two of Pilot Enhanced Oil Recovery onshore Trinidad using injected carbon dioxide.

----------

Solo Oil PLC - AIM-listed oil investment company - For the first half of 2020, pretax loss was GBP1.3 million, widened from GBP800,000. During period, did not proceed with acquisition of offshore Netherlands assets from ONE Dyas. Is continuing to screen acquisition opportunities.

----------

Triple Point Social Housing REIT PLC - London-based real estate investment trust - As at June 30, net asset value per share is up at 105.34 pence from 103.96p the year before. For the six month-period, annualised rental income rose to GBP28.0 million from GBP21.1 million. However, pretax profit dropped to GBP9.0 million from GBP9.9 million. Dividend per share up at 2.59 pence from 2.54p. Plans to raise GBP70 million through a placing, open offer and subscription of shares at price of 106 pence each.

----------

Open Orphan PLC - pharmaceutical services company - For the first half of 2020, pretax loss widens to GBP6.8 million from GBP1.1 million, despite generating revenue of GBP7.1 million.

----------

Provexis PLC - health food ingredient maker - For the year to the end of March, pretax loss narrows to GBP424,465 from GBP533,375, on revenue that rose by 8% to GBP347,937 from GBP322,189 the year before, through high product sales.

----------

SIMEC Atlantis Energy Ltd - London-based developer of renewable and sustainable energy projects - For the first half of 2020, pretax loss narrows to GBP6.2 million from GBP12.4 million the year before, as revenue rose sharply to GBP7.9 million from GBP2.0 million, from contributions generated by the Atlantis tidal turbine and engineering services division.

----------

Trafalgar Property Group PLC - residential homes developer based in Kent - For the year to the end of March, pretax loss narrows to GBP1.0 million from GBP2.3 million, due to a smaller writing off of assets. Revenue dipped to GBP2.0 million from GBP2.1 million, reflecting the sale of two assets, compared to five assets the prior year.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
13 Dec 2019 12:12

ImmuPharma To List On Life Sciences Heavy Brussels Index

ImmuPharma To List On Life Sciences Heavy Brussels Index

Read more
11 Dec 2019 14:54

ImmuPharma says not looking to raise funds

(Sharecast News) - AIM-listed specialist drug discovery and development company ImmuPharma insisted on Wednesday that it is not looking to raise funds.

Read more
11 Dec 2019 14:03

ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise

ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise

Read more
28 Nov 2019 16:26

ImmuPharma shares soar as it teams up with Avion on Lupuzor

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced a licence and development agreement with Avion Pharmaceuticals on Thursday, for the exclusive rights to 'Lupuzor' in the United States.

Read more
28 Nov 2019 12:02

Immupharma Shares Take Off On Lupuzor US Licencing Deal With Avion

Immupharma Shares Take Off On Lupuzor US Licencing Deal With Avion

Read more
28 Nov 2019 07:28

ImmuPharma licenses lupus drug Lupuzor to Avion in the United States

LONDON, Nov 28 (Reuters) - British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals....

Read more
30 Sep 2019 10:40

ImmuPharma Loss Narrows Slightly, Focus On Lupuzor Regulatory Approval

ImmuPharma Loss Narrows Slightly, Focus On Lupuzor Regulatory Approval

Read more
28 Jun 2019 12:01

Immupharma Study Demonstrates Robust Safety Profile Of Lupuzor

(Alliance News) - Immupharma PLC on Friday reported analysis of the results from the study of Lupuzor, its lead programme for the potential breakthrough compound for Lupus, a potentially life drug

Read more
28 Jun 2019 10:27

ImmuPharma pleased with Lupuzor open-label study results

(Sharecast News) - Specialist drug discovery and development company ImmuPharma released the analysis of results from the open-label six month extension study from its original pivotal phase 3 trial of 'Lupuzor' on Friday.

Read more
26 Jun 2019 11:15

Immupharma raises ?2.66m from subscription agreement with institutional investor

(Sharecast News) - Drug discovery and development specialist Immupharma raised roughly £2.66m via a subscription agreement with institutional investor Lanstead Capital on Wednesday.

Read more
26 Jun 2019 10:14

Immupharma Raises GBP2.7 Million From Share Subscription With Lanstead

(Alliance News) - Immupharma PLC on Wednesday announced a 26.6 million share subscription to raise around GBP2.7 million at a price of 10 pence per share.The drug discovery and development

Read more
24 May 2019 11:47

Immupharma 2018 Loss Widens Amid Placing; Progresses On Pipeline

LONDON (Alliance News) - Drug development firm Immupharma PLC said Friday its 2018 loss widened amid share placing costs, whilst it continued to make "key" progress in its 2018, pretax a

Read more
7 May 2019 11:06

ImmuPharma Exploring European Listing For Combined French Businesses (ALLIPO)

LONDON (Alliance News) - ImmuPharma PLC is exploring the merger and possible separate listing of two French subsidiaries, it said Tuesday.Elro Pharma Sarl and Ureka Sarl are currently on a

Read more
1 Apr 2019 14:07

ImmuPharma Loses Exclusivity Period For Talks With Incanthera

LONDON (Alliance News) - ImmuPharma PLC on Monday said proposed partner Incanthera Ltd can now talk with other potential parties after an exclusivity period ended.In September, ImmuPharma a

Read more
14 Mar 2019 11:04

ImmuPharma struggles to convince investors in latest update

(Sharecast News) - Shares in ImmuPharma fell even further on Thursday, as the ailing drug development company struggled to give shareholders some reassurance about its future in an update.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.